Access to this article is restricted until 12 months after publication by request of the publisher. Restriction lift date: 45635
STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: uptake and clinical impact
Loading...
Files
Accepted Version
Date
45269
Authors
McGettigan, Siobhán
Curtin, Denis
O’Mahony, Denis
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor & Francis
Published Version
Abstract
Introduction: STOPP/START criteria for potentially inappropriate medications (PIMs, STOPP) and potential prescribing omissions (PPOs, START) have gained considerable interest and traction since they were first published in 2008. This review focuses on their uptake and impact in various clinical settings. Areas covered: STOPP/START criteria, now in their third iteration, are explicit criteria designed to facilitate detection of common and clinically important PIMs and PPOs during routine medication review in any clinical setting. We examine the influence of the criteria, particularly in clinical trials that focused on their impact on clinically relevant endpoints. Expert opinion: STOPP/START criteria are widely used in several countries within Europe and beyond for medication review and audit. As a discreet intervention, the criteria have been tested in several single-center and two large-scale multi-center clinical trials. The single-center trials indicate that STOPP/START criteria reduce polypharmacy, inappropriate prescribing, ADRs (adverse drug reactions), medication cost and falls. In contrast, the SENATOR and OPERAM multicentre trials did not demonstrate significant reduction in ADRs, all-cause mortality, drug-related hospital readmissions, nor any improvement in quality-of-life. Further clinical trials are required to examine whether STOPP/START criteria as an intervention can deliver significant clinical benefit in a reproducible manner in various clinical settings.
Description
Keywords
Polypharmacy , STOPP/START criteria , Older people , Adverse drug events , Medication review , Multimorbidity , Deprescribing , Inappropriate prescribing
Citation
McGettigan, S., Curtin, D. and O’Mahony, D. (2023) 'STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: uptake and clinical impact', Expert Review of Clinical Pharmacology, 16(12), pp. 1175-1185. doi: https://doi.org/10.1080/17512433.2023.2280219